Parkinsonism, Tardive Dyskinesia, Akathisia, & Depression Induced by Flunarizine
Lancet 1:1303-1304, Chouza,C.,et al, 1986
Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986
Persistent Vegetative State, Extension of the Syndrome to Include Chronic Disorders
Arch Neurol 42:1045-1047, Walshe,T.M.&Leonard,C., 1985
Prolactinomas
Editorial, BMJ 290:182-1841985., Grossman,A.,et al, 1985
Low Dosages of Bromocriptine Added to Levodopa in Parkinson's Disease
Neurol 35:199-206, Maier,M.M.,et al, 1985
Long-Term Study of Pergolide in Parkinson's Disease
Neurol 35:296-299, Jankovic,J., 1985
Placebo-Controlled Study of Mesulergine in Parkinson's Disease
Neurol 35:161-165, Jankovic,J.,et al, 1985
Hyperthermia after Discontinuance of Levodopa & Bromocriptine Therapy:Impaired Dopamine Receptors a Possible Cause
Neurol 35:258-261, Figa-Talamanca,L.,et al, 1985
Syndrome of Palatal Myoclonus & Progressive Ataxia:Two Cases with Magnetic Resonance Imaging
Neurol 35:1212-1214, Sperling,M.R.&Herrman,C., 1985
Low Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas
NEJM 313:656-659, Liuzzi,A.,et al, 1985
Cerebrospinal Fluid Rhinorrhea During Treatment with Bromocriptine for Prolactinoma
Neurol 35:1193-1195, Kok,J.G.,et al, 1985
Low-Dose Bromocriptine Therapy in Parkinson's Disease
Arch Neurol 42:586-588, Pfeiffer,R.F.,et al, 1985
Mesulergin (CU32-085) in the Treatment of Parkinson's Disease
Ann Neurol 17:334-336, Pfeiffer,R.F.,et al, 1985
Neuroleptic Malignant Syndrome
NEJM 313:163-166, Guze,B.H.,et al, 1985
Calcium Channel Blockers in the Prophylactic Treatment of Vascular Headache
Ann Int Med 102:395-397, Meyer,J.S., 1985
Dysosmia, Dysguesia, & Nifedipine
Ann Int Med 102:135-136, 7171985., Levenson,J.L.&Kennedy,K., 1985
Flunarizine in Alternating Hemiplegia in Childhood
Lancet 2:579-580, Casaer,P.,et al, 1984
Psychotic Reactions During Treatment of Pituitary Tumours with Dopamine Agonists
BMJ 289:1101-1103, Turner,T.H.,et al, 1984
Effect of Dopamine Agonist Withdrawal After Long-Term Therapy in Prolactinomas
Lancet 2:187-192, Johnston,D.G.,et al, 1984
Familial Multisystem Atrophy with Possible Thalamic Dementia
Neurol 34:1213-1217, Katz,D.A.,et al, 1984
Fibrotic Processes Associated with Long-Term Ergotamine Therapy
NEJM 311:601-602, Robert,M.,et al, 1984
Thromboembolism in Patients with Atrial Fibrillation
Arch Neurol 41:708-710, Sherman,D.G.,et al, 1984
Neuroleptic Malignant Syndrome
Lancet 1:545-546, Smego,R.A.,et al, 1984
Cerebrospinal Fluid Rhinorrhea Caused by Bromocriptine Therapy of Prolactinoma
Neurol 34:111-113, Holness,R.O.,et al, 1984
Treatment of Prolactinomas with Megavoltage Radiotherapy
BMJ 288:1105-1109, Grossman,A.,et al, 1984
Diltiazem Prophylaxis in Refractory Migraine
NEJM 310:1327-1328, Smith,R.,et al, 1984
Rapid Size Reduction of Giant Prolactinoma Following Medical Treatment
J Comput Assist Tomogr 8:131-133, Perani,D.,et al, 1984
Pergolide in the Treatment of Parkinson's Disease
Neurol 34:983-986, Mear,J.,et al, 1984
A New Form of Sea-blue Histiocytosis Associated with Progressive Anterior Horn Cell & Axonal Degeneration
Ann Neurol 16:184-192, Ashwal,S.,et al, 1984
Verapamil in Prophylactic Therapy of Migraine
Neurol 34:973-976, Markley,H.G.,et al, 1984
Hyperprolactinemia
Am J Med 75:868-874, Johnston,D.G.,et al, 1983
Urinary Incontinence in Patient on Long-Term Bromocriptine
Lancet 2:1260-1261, Sandyk,R.,et al, 1983
Transient Retinal Ischaemia Induced by Nifedipine
BMJ 287:1845-1846, Pitlik,S.,et al, 1983
Verapamil Prophylaxis of Migraine
JAMA 250:2500-2502, Solomon,G.D.,et al, 1983
Cerebral Arterial Spasm-A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage
NEJM 308:619-624, Allen,G.S.,et al, 1983
Calcium Antagonists & Aneurysmal Subarachnoid Hemorrhage
Lancet 2:141-143, , 1983
Progressive Supranuclear Palsy:Clinical Features & Response to Treatment in 16 Patients
Ann Neurol 13:273-278, Jackson,J.A.,et al, 1983
Nifedipine in the Treatment of Migraine in Patients with Raynaud's Phenomenon
NEJM 308:1102-1103, Kahan,A.,et al, 1983
Failure of Bromocriptine to Maintain Reduction in Size of a Macroprolactinoma
BMJ 287:451-452, Breidahl,H.D.,et al, 1983
Treatment of Acromegaly
BMJ 286:330-332, Thomas,J.P., 1983
Bromocriptine & Lisuride in Parkinson Disease
Ann Neurol 13:44-47, Lieberman,A.N.,et al, 1983
Comparison of Pergolide & Bromocriptine Therapy in Parkinsonism
Neurol 33:1009-1014, LeWitt,P.A.,et al, 1983
Clin. Path. Conference
Multiple-System Atrophy with Parkinsonism, Case 28-13, NEJM 308:1406-1414983., , 1983
Neurodegenerative Disease of Infancy & Childhood
Ann Neurol 13:351-364, Dyken,P.,et al, 1983
Neuroleptic Malignant Syndrome:Successful Treatment with Dantolene & Bromocriptine
Ann Neurol 14:89-90, Granato,J.E.,et al, 1983
Neuroleptic Malignant Syndrome, Successful Treatment with Bromocriptine
JAMA 249:386-388, Mueller,P.S.,et al, 1983
Pergolide in Parkinson's Disease
Arch Neurol 40:785-787, Goetz,C.G.,et al, 1983
Effect of Carbamazepine on Coumadin Metabolism
Ann Neurol 13:691-692, Massey,E.W., 1983
Drug Interaction with Coumarin Derivative Anticoagulants
BMJ 285:274-275, Sharp,A.A., 1982
Lisuride Versus Bromocriptine Treatment in Parkinson Disease:A Double-blind Study
Neurol 32:69-72, LeWitt,P.A.,et al, 1982